⌘K
Loading ticker…
As of 2026-08-24, LeMaitre Vascular, Inc. (LMAT) has a 3-month relative strength percentile of 22 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.7%, relative volume 1.27×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
LMAT is in a stage 3 topping pattern, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -14.8% / -16.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
LMAT appears in 1 ETF as of Jun 2026: PSC at 0.07% weight, $2M notional.
Held by 97 ETFs · $611M across latest filings · largest weight 3.07% (SCDV).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.07% | $2M | −0.03 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LMAT Jan avg: 3.69% median: 3.65% win: 100% σ: 1.51% n: 4 2022-04-12 → 2026-07-31 | LMAT Feb avg: 12.22% median: 13.41% win: 75% σ: 14.60% n: 4 2022-04-12 → 2026-07-31 | LMAT Mar avg: -2.56% median: -2.14% win: 50% σ: 5.29% n: 4 2022-04-12 → 2026-07-31 | LMAT Apr avg: 1.19% median: 0.53% win: 60% σ: 5.42% n: 5 2022-04-12 → 2026-07-31 | LMAT May avg: 4.15% median: 5.81% win: 60% σ: 15.54% n: 5 2022-04-12 → 2026-07-31 | LMAT Jun avg: 2.68% median: 1.38% win: 80% σ: 2.98% n: 5 2022-04-12 → 2026-07-31 | LMAT Jul avg: 2.71% median: 5.59% win: 60% σ: 6.67% n: 5 2022-04-12 → 2026-07-31 | LMAT Aug avg: 2.70% median: 0.99% win: 50% σ: 11.04% n: 4 2022-04-12 → 2026-07-31 (current) | LMAT Sep avg: -2.12% median: -1.56% win: 50% σ: 5.72% n: 4 2022-04-12 → 2026-07-31 | LMAT Oct avg: -7.77% median: -7.84% win: 0% σ: 5.97% n: 4 2022-04-12 → 2026-07-31 | LMAT Nov avg: 8.31% median: 8.21% win: 75% σ: 10.32% n: 4 2022-04-12 → 2026-07-31 | LMAT Dec avg: -2.54% median: -2.00% win: 25% σ: 8.84% n: 4 2022-04-12 → 2026-07-31 |